The beneficial effect of tirzepatide on hsCRP, a biomarker of systemic inflammation, YKL-40, a proinflammatory cytokine, and ICAM-1, a biomarker of endothelial dysfunction, was already detectable at 4 weeks, consistent with the salutary effects of GIP and GLP-1 on inflammation and atherosclerosis in experimental models [84,85,86]
A qualified healthcare provider should evaluate your medical history, medications, contraindications, and metabolic status before recommending any weight-loss approach
[9] [7] Patients are advised to: Only obtain medicines from GPhC-registered UK pharmacies , identifiable by the registered pharmacy logo on their website verify any online pharmacy via the GPhC register before purchasing Check whether a medicine is licensed in the UK using the electronic Medicines Compendium (emc) at medicines.org.uk or the NHS medicines pages, which provide patient-friendly summaries of approved treatments Report suspected illegal medicine sales via the MHRA's dedicated reporting portal on GOV.UK, or contact Trading Standards Report any suspected side effects or product problems via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk The MHRA also collaborates with NHS England and Trading Standards to investigate and shut down illegal online suppliers
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE (-/-) mice
FDA scrutiny of misleading compounded GLP-1 promotion also raises the value of platforms that clearly separate clinical prescribing from product advertising